FDA Inspection 1089644 — Elusys Therapeutics Inc
The FDA completed an inspection of Elusys Therapeutics Inc on May 8, 2019 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Parsippany, NJ (United States)